Krista Qualmann on the Effect of Genetic Testing on Treatment in Brain Cancer

Krista Qualmann, MS, CGC
Published Online: Friday, Nov 18, 2016


Krista Qualmann, MS, CGC, genetic counselor at the Memorial Hermann Mischer Neuroscience Institute at the Texas Medical Center and UTHealth, discusses the implications that genetic testing results can have on treatment options for patients with brain cancer.

For some hereditary syndromes, certain treatments might be more or less effective. As an example, patients with low-grade gliomas and certain syndromes should avoid ionizing radiation, Qualmann says. Additionally, testing is important to keep in mind when considering screening for other cancers. Many syndromes, including Li-Fraumeni syndrome, can put a patient at higher risk for other cancer types.
<<< View more from the 2016 SNO Annual Meeting

Krista Qualmann, MS, CGC, genetic counselor at the Memorial Hermann Mischer Neuroscience Institute at the Texas Medical Center and UTHealth, discusses the implications that genetic testing results can have on treatment options for patients with brain cancer.

For some hereditary syndromes, certain treatments might be more or less effective. As an example, patients with low-grade gliomas and certain syndromes should avoid ionizing radiation, Qualmann says. Additionally, testing is important to keep in mind when considering screening for other cancers. Many syndromes, including Li-Fraumeni syndrome, can put a patient at higher risk for other cancer types.
<<< View more from the 2016 SNO Annual Meeting

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesJan 30, 20182.0
Medical Crossfire®: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future DirectionJan 30, 20181.5
Publication Bottom Border
Border Publication
x